Table 3.
Comparison of observed (7-year) and total prevalence of the top five hematological malignancies by gender in the UK
| Observed | Total | ||
|---|---|---|---|
| Disease | Prevalence | Disease | Prevalence |
| Male | Male | ||
| Chronic lymphocytic leukemia | 13,300 | Chronic lymphocytic leukemia | 23,222 |
| Monoclonal gammopathy of undetermined significance | 10,772 | Hodgkin lymphoma | 20,950 |
| Diffuse large B cell lymphoma | 9,847 | Monoclonal gammopathy of undetermined significance | 18,274 |
| Myeloproliferative neoplasms | 9,268 | Myeloproliferative neoplasms | 18,007 |
| Plasma cell myeloma | 7,352 | Diffuse large B cell lymphoma | 17,483 |
| Female | Female | ||
| Myeloproliferative neoplasms | 11,536 | Monoclonal gammopathy of undetermined significance | 24,020 |
| Monoclonal gammopathy of undetermined significance | 9,878 | Hodgkin lymphoma | 21,608 |
| Diffuse large B cell lymphoma | 8,664 | Myeloproliferative neoplasms | 21,515 |
| Chronic lymphocytic leukemia | 7,827 | Diffuse large B cell lymphoma | 14,924 |
| Follicular lymphoma | 5,825 | Chronic lymphocytic leukemia | 13,316 |